Showing results (391-400 of 654) with videos related to
Sort By:
Pageof 66
Cancer Immunology Research|April 26, 2014
PD-L1 expression in triple-negative breast cancerElizabeth A Mittendorf, Anne V Philips, Funda Meric-Bernstam, et al.Journal of Medical Internet Research|March 15, 2019
Cancer-Related Internet Use and Its Association With Patient Decision Making and Trust in Physicians Among Patients in an Early Drug Development Clinic: A Questionnaire-Based Cross-Sectional Observational StudyGoldy C George, Eucharia C Iwuanyanwu, Adrianna S Buford, et al.Nature Communications|May 9, 2025
Zanidatamab monotherapy or combined with chemotherapy in HER2-expressing gastroesophageal adenocarcinoma: a phase 1 trialFunda Meric-Bernstam, Sun Young Rha, Erika Hamilton, et al.Journal of the American College of Surgeons|June 27, 2006
Use of lymphoscintigraphy defines lymphatic drainage patterns before sentinel lymph node biopsy for breast cancerKazumi Kawase, Isis W Gayed, Kelly K Hunt, et al.Cancer|February 26, 2004
Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situTina W F Yen, Kelly K Hunt, Nadeem Q Mirza, et al.Breast Cancer Research : BCR|March 5, 2021
First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer modelsSeyed Pairawan, Ming Zhao, Erkan Yuca, et al.The Oncologist|October 6, 2022
Mutation-Agnostic Detection of Colorectal Cancer Using Liquid Biopsy-Based Methylation-Specific SignaturesMohamed A Gouda, Dzifa Y Duose, Morten Lapin, et al.Cancer|April 24, 2018
Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panelsCourtney D DiNardo, Mark J Routbort, Sarah A Bannon, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2019
Alpha Particle Radium 223 Dichloride in High-risk Osteosarcoma: A Phase I Dose Escalation TrialVivek Subbiah, Pete M Anderson, Kalevi Kairemo, et al.JCO Precision Oncology|September 14, 2020
Identification of Actionable Genomic Alterations Using Circulating Cell-Free DNANora S Sánchez, Michael P Kahle, Ann Marie Bailey, et al.Pageof 66